Calumet Specialty Products Stock Today

CLMT Stock  USD 14.38  0.58  4.20%   

Performance

0 of 100

 
Low
 
High
Very Weak

Odds Of Distress

Less than 31

 
100  
 
Zero
Below Average
Calumet Specialty is selling for under 14.38 as of the 28th of March 2024; that is 4.20% increase since the beginning of the trading day. The stock's last reported lowest price was 13.81. Calumet Specialty has about a 31 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Calumet Specialty Products are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of February 2024 and ending today, the 28th of March 2024. Click here to learn more.
Business Domain
Energy
IPO Date
26th of January 2006
Calumet Specialty Products Partners, L.P. manufactures, formulates, and markets slate of specialty branded products to various consumer-facing and industrial markets in North America and internationally. The company was founded in 1916 and is headquartered in Indianapolis, Indiana. The company has 80.22 M outstanding shares of which 830.52 K shares are currently shorted by private and institutional investors with about 6.08 trading days to cover. More on Calumet Specialty Products

Moving together with Calumet Stock

  0.7EP Empire Petroleum CorpPairCorr

Moving against Calumet Stock

  0.86VIST Vista Oil Gas Financial Report 23rd of April 2024 PairCorr
  0.81SD SandRidge EnergyPairCorr
  0.74PR Permian Resources Financial Report 13th of May 2024 PairCorr
  0.73DMLP Dorchester MineralsPairCorr
  0.72SM SM Energy Financial Report 25th of April 2024 PairCorr
  0.67FANG Diamondback Energy Financial Report 6th of May 2024 PairCorr
  0.66MTDR Matador Resources Financial Report 23rd of April 2024 PairCorr

Calumet Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Calumet Specialty's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Calumet Specialty or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO of Calumet GP LLCTimothy Go
Old NamePurpose Global Climate Opportunities Fund ETF
Business ConcentrationOil & Gas Refining & Marketing, Oil & Gas E&P, Energy, NASDAQ Composite, NASDAQ Composite Total, Energy, Oil, Gas & Consumable Fuels, Oil & Gas E&P, Energy (View all Sectors)
Average Analyst Recommendation
Analysts covering Calumet Specialty report their recommendations after researching Calumet Specialty's financial statements, talking to executives and customers, or listening in on Calumet Specialty's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Calumet Specialty. The Calumet consensus assessment is calculated by taking the average forecast from all of the analysts covering Calumet Specialty.
Financial Strength
Based on the key measurements obtained from Calumet Specialty's financial statements, Calumet Specialty Products is doing better financially then in previous quarter. It has a moderate likelihood of reporting better financial numbers in April. Financial strength of Calumet Specialty is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover2.091.5196
Significantly Up
Pretty Stable
Gross Profit Margin0.110.1201
Significantly Down
Very volatile
Net Debt1.1 B2.2 B
Way Down
Slightly volatile
Total Current Liabilities1.2 B1.1 B
Sufficiently Up
Slightly volatile
Non Current Liabilities Total1.2 B1.9 B
Way Down
Slightly volatile
Total Assets1.8 B2.8 B
Way Down
Pretty Stable
Total Current Assets650.2 M794.7 M
Significantly Down
Very volatile
Calumet Specialty's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Calumet Specialty's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Calumet Specialty's financial leverage. It provides some insight into what part of Calumet Specialty's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Calumet Specialty's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Calumet Specialty deploys its capital and how much of that capital is borrowed.
Liquidity
Calumet Specialty cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 2.19 B in liabilities. Calumet Specialty has a current ratio of 0.59, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Calumet Specialty until it has trouble settling it off, either with new capital or with free cash flow. So, Calumet Specialty's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Calumet Specialty sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Calumet to invest in growth at high rates of return. When we think about Calumet Specialty's use of debt, we should always consider it together with cash and equity.

Total Cash From Financing Activities

279.51 Million
Calumet Specialty Products (CLMT) is traded on NASDAQ Exchange in USA. It is located in 2780 Waterfront Parkway East Drive, Indianapolis, IN, United States, 46214 and employs 1,580 people. Calumet Specialty is listed under Oil & Gas Refining & Marketing category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.15 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Calumet Specialty's market, we take the total number of its shares issued and multiply it by Calumet Specialty's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Calumet Specialty conducts business under Oil, Gas & Consumable Fuels sector and is part of Energy industry. The entity has 80.22 M outstanding shares of which 830.52 K shares are currently shorted by private and institutional investors with about 6.08 trading days to cover. Calumet Specialty Products currently holds about 50.5 M in cash with (14.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.64.
Check Calumet Specialty Probability Of Bankruptcy
Ownership Allocation
Calumet Specialty holds a total of 80.22 Million outstanding shares. 30% of Calumet Specialty Products outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Calumet Ownership Details

Calumet Stock Price Odds Analysis

Attributed to a normal probability distribution, the odds of Calumet Specialty jumping above the current price in 90 days from now is more than 93.0%. The Calumet Specialty Products probability density function shows the probability of Calumet Specialty stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.0381 suggesting Calumet Specialty Products market returns are related to returns on the market. As the market goes up or down, Calumet Specialty is expected to follow. Additionally, calumet Specialty Products has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
  Odds Below 14.38HorizonTargetOdds Above 14.38
6.79%90 days
 14.38 
93.15%
Based on a normal probability distribution, the odds of Calumet Specialty to move above the current price in 90 days from now is more than 93.0 (This Calumet Specialty Products probability density function shows the probability of Calumet Stock to fall within a particular range of prices over 90 days) .

Calumet Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Calumet Specialty that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Calumet Specialty's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Calumet Specialty's value.
InstituionRecorded OnShares
Royal Bank Of Canada2023-12-31
310.3 K
Barnett & Co Inc2023-12-31
284.7 K
Lpl Financial Corp2023-12-31
172.8 K
Morgan Stanley - Brokerage Accounts2023-12-31
171.8 K
Citadel Advisors Llc2023-09-30
161.7 K
Linscomb & Williams, Inc.2023-12-31
110.9 K
Ing Groep Nv2023-12-31
95 K
Brown Advisory Holdings Inc2023-12-31
85.6 K
Epacria Capital Partners Llc2023-12-31
77.5 K
Wasserstein Debt Opportunities Management Lp2023-12-31
6.7 M
Adams Asset Advisors Llc2023-12-31
5.4 M
View Calumet Specialty Diagnostics

Calumet Specialty Historical Income Statement

Calumet Specialty Products Income Statement is one of the three primary financial statements used for reporting Calumet's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Calumet Specialty revenue and expense. Calumet Specialty Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Calumet Specialty's Net Income is comparatively stable compared to the past year. Selling And Marketing Expenses is likely to gain to about 61 M in 2024, whereas Other Operating Expenses is likely to drop slightly above 3 B in 2024. View More Fundamentals

Calumet Stock Against Markets

Picking the right benchmark for Calumet Specialty stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Calumet Specialty stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Calumet Specialty is critical whether you are bullish or bearish towards Calumet Specialty Products at a given time. Please also check how Calumet Specialty's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Calumet Specialty without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Positions Ratings Now

   

Positions Ratings

Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Calumet Specialty Corporate Directors

Calumet Specialty corporate directors refer to members of a Calumet Specialty board of directors. The board of directors generally takes responsibility for the Calumet Specialty's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Calumet Specialty's board members must vote for the resolution. The Calumet Specialty board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
George MorrisIndependent Director of Calumet GP LLCProfile
Daniel SheetsIndependent Director of the Calumet GP, LLCProfile
Amy SchumacherDirector of Calumet GP, LLCProfile
Daniel SajkowskiDirectors of Calumet GP, LLCProfile

How to buy Calumet Stock?

Before investing in Calumet Specialty, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Calumet Specialty. To buy Calumet Specialty stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Calumet Specialty. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Calumet Specialty stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Calumet Specialty Products stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Calumet Specialty Products stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Calumet Specialty Products, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Calumet Stock please use our How to Invest in Calumet Specialty guide.

Already Invested in Calumet Specialty Products?

The danger of trading Calumet Specialty Products is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Calumet Specialty is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Calumet Specialty. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Calumet Specialty is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Calumet Specialty is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Calumet Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Calumet Specialty Products Stock. Highlighted below are key reports to facilitate an investment decision about Calumet Specialty Products Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Calumet Specialty Products. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Calumet Stock analysis

When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Is Calumet Specialty's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Calumet Specialty. If investors know Calumet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Calumet Specialty listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
5.617
Earnings Share
0.59
Revenue Per Share
52.213
Quarterly Revenue Growth
(0.02)
Return On Assets
0.0599
The market value of Calumet Specialty is measured differently than its book value, which is the value of Calumet that is recorded on the company's balance sheet. Investors also form their own opinion of Calumet Specialty's value that differs from its market value or its book value, called intrinsic value, which is Calumet Specialty's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Calumet Specialty's market value can be influenced by many factors that don't directly affect Calumet Specialty's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Calumet Specialty's value and its price as these two are different measures arrived at by different means. Investors typically determine if Calumet Specialty is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Calumet Specialty's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.